ARCHIVES

ODAC Recommendation for Pertuzumab Signals FDA’s Resolve In Granting Accelerated Approvals

This article is from The Cancer Letter archive.

Vol. 39 No. 35 | September 20, 2013

Download PDF Visit The Full Archive

Related Articles

Health Canada Suspends Avastin Approval; CMS Has Taken No Action After FDA Decision

December 2, 2011

Obey Continue Crusade On Carcinogenesis, Attack On DCCP, Shubik

April 1, 1977

Review Group Urges Increased Funding For NCI AIDS Drug Discovery Program

December 3, 1999

NCI director recognizes work of staff.

October 17, 2003

Construction Report Scheduled for NCAB

August 25, 1978

HHS Awards $85 Million For Research to Eliminate Health Disparities

November 15, 2002